Publication | Closed Access

Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model

Pulmonary TuberculosisThree-drug CombinationsMycobacterium Tuberculosis IsolatesMedicineTuberculosisHuman Macrophage ModelAntibacterial AgentMicrobiologyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug Discovery